AI-generated summary
The authors report a randomized, double-blind, placebo-controlled trial in women aged 18 to 35 with primary dysmenorrhea at two South Korean university hospitals. Menstrual pain reduction after three months was greater in the low-level light therapy group than in the placebo group, and no serious adverse events occurred.
- Who or what was studied
- Women aged 18 to 35 years with primary dysmenorrhea treated at two university hospitals in South Korea
- Limits stated in the abstract
- The abstract does not report the wavelength used by the device, and the number of patients analyzed (41 and 38) was smaller than the 44 per group originally assigned.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on doi.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Randomized controlled trial, Placebo-controlled, Primary outcome, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.